Quiz-summary
0 of 31 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
Information
6 ORAL HYPOGLYCAEMIC DRUGS
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
0 of 31 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 points, (0)
Average score |
|
Your score |
|
Categories
- Not categorized 0%
-
You need to review the course to improve your result.
-
That’s good, feel free to review the course to improve your result.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- Answered
- Review
-
Question 1 of 31
1. Question
The following drugs enhance the effect of insulin Sulphonylureas (e.g. glibenclamide)
Correct
Incorrect
-
Question 2 of 31
2. Question
The following drugs enhance the effect of insulin Biguanides (e.g. metformin)
Correct
Incorrect
-
Question 3 of 31
3. Question
The following drugs enhance the effect of insulin Thiazolidiones (e.g. Pioglitazone)
Correct
Incorrect
-
Question 4 of 31
4. Question
The following drugs enhance the effect of insulin Arcarbose
Correct
Incorrect
-
Question 5 of 31
5. Question
The following drugs enhance the effect of insulin Repaglinidine
Correct
Incorrect
-
Question 6 of 31
6. Question
In the 5 groups of oral anti-diabetic drugs
- A ) Sulphonyl ureas
- B ) Pradial glucose regulators (meglitinides)
- C ) Biguanides
- D ) Insulin sinsitizers
- E ) Alpha-glucosidase inhibitors
Drugs from all groups could be combined except for : A + B
Correct
Incorrect
-
Question 7 of 31
7. Question
In the 5 groups of oral anti-diabetic drugs
- A ) Sulphonyl ureas
- B ) Pradial glucose regulators (meglitinides)
- C ) Biguanides
- D ) Insulin sinsitizers
- E ) Alpha-glucosidase inhibitors
Drugs from all groups could be combined except for : B + E
Correct
Incorrect
-
Question 8 of 31
8. Question
The following are indications for sulponylurea (SU) When diet and weight reduction do not achieve predetermined glycaemic goals
Correct
Incorrect
-
Question 9 of 31
9. Question
The following are indications for sulponylurea (SU) Elderly on small dose of insulin can be switched to SU
Correct
Incorrect
-
Question 10 of 31
10. Question
The following are indications for sulponylurea (SU) Elderly with visual problem if insulin need is less
Correct
Incorrect
-
Question 11 of 31
11. Question
The following are indications for sulponylurea (SU) DM controlled with diet during intercurrent infections
Correct
Incorrect
-
Question 12 of 31
12. Question
Sulphonyl ureas are contraindicated in: Pregnancy
Correct
Incorrect
-
Question 13 of 31
13. Question
Sulphonyl ureas are contraindicated in: Type 1 diabetes
Correct
Incorrect
-
Question 14 of 31
14. Question
Sulphonyl ureas are contraindicated in: Diabetic ketoacidosis
Correct
Incorrect
-
Question 15 of 31
15. Question
Sulphonyl ureas are contraindicated in: Severe renal failure
Correct
Incorrect
-
Question 16 of 31
16. Question
The following are true regarding sulphonyl ureas Can be combined with other non SU agents and insulin
Correct
Incorrect
-
Question 17 of 31
17. Question
The following are true regarding sulphonyl ureas They are ineffective in 10-20% of people on first use
Correct
Incorrect
-
Question 18 of 31
18. Question
The following are true regarding sulphonyl ureas About 5-10% will fail to respond for each subsequent year of use
Correct
Incorrect
-
Question 19 of 31
19. Question
Reasons for failure to respond to sulphonyl ureas include: Decreasing beta-cell function
Correct
Incorrect
-
Question 20 of 31
20. Question
Reasons for failure to respond to sulphonyl ureas include: Nonadherence to treatment
Correct
Incorrect
-
Question 21 of 31
21. Question
Reasons for failure to respond to sulphonyl ureas include: Obesity
Correct
Incorrect
-
Question 22 of 31
22. Question
Reasons for failure to respond to sulphonyl ureas include: Insufficient exercise
Correct
Incorrect
-
Question 23 of 31
23. Question
Reasons for failure to respond to sulphonyl ureas include: Stress including intercurrent illness
Correct
Incorrect
-
Question 24 of 31
24. Question
The treatment of choice in a thin type 2 diabetes is: Sulphonyl urea, if fails then add metformin, if fails add insulin
Correct
Incorrect
-
Question 25 of 31
25. Question
The treatment of choice in a thin type 2 diabetes is: Sulphonyl urea, if fails then replace with metformin, if fails add insulin
Correct
Incorrect
-
Question 26 of 31
26. Question
The treatment of choice in a thin type 2 diabetes is: Sulphonyl urea, if fails then add metformin, if fails replace with insulin
Correct
Incorrect
-
Question 27 of 31
27. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add insulin
Correct
Incorrect
-
Question 28 of 31
28. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add sulphonyl urea
Correct
Incorrect
-
Question 29 of 31
29. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add Pioglitazone
Correct
Incorrect
-
Question 30 of 31
30. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add an incretin
Correct
Incorrect
-
Question 31 of 31
31. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Perform metabolic surgery
Correct
Incorrect
Quiz-summary
0 of 31 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
Information
6 ORAL HYPOGLYCAEMIC DRUGS
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
0 of 31 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 points, (0)
Average score |
|
Your score |
|
Categories
- Not categorized 0%
-
You need to review the course to improve your result.
-
That’s good, feel free to review the course to improve your result.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- Answered
- Review
-
Question 1 of 31
1. Question
The following drugs enhance the effect of insulin Sulphonylureas (e.g. glibenclamide)
Correct
Incorrect
-
Question 2 of 31
2. Question
The following drugs enhance the effect of insulin Biguanides (e.g. metformin)
Correct
Incorrect
-
Question 3 of 31
3. Question
The following drugs enhance the effect of insulin Thiazolidiones (e.g. Pioglitazone)
Correct
Incorrect
-
Question 4 of 31
4. Question
The following drugs enhance the effect of insulin Arcarbose
Correct
Incorrect
-
Question 5 of 31
5. Question
The following drugs enhance the effect of insulin Repaglinidine
Correct
Incorrect
-
Question 6 of 31
6. Question
In the 5 groups of oral anti-diabetic drugs
- A ) Sulphonyl ureas
- B ) Pradial glucose regulators (meglitinides)
- C ) Biguanides
- D ) Insulin sinsitizers
- E ) Alpha-glucosidase inhibitors
Drugs from all groups could be combined except for : A + B
Correct
Incorrect
-
Question 7 of 31
7. Question
In the 5 groups of oral anti-diabetic drugs
- A ) Sulphonyl ureas
- B ) Pradial glucose regulators (meglitinides)
- C ) Biguanides
- D ) Insulin sinsitizers
- E ) Alpha-glucosidase inhibitors
Drugs from all groups could be combined except for : B + E
Correct
Incorrect
-
Question 8 of 31
8. Question
The following are indications for sulponylurea (SU) When diet and weight reduction do not achieve predetermined glycaemic goals
Correct
Incorrect
-
Question 9 of 31
9. Question
The following are indications for sulponylurea (SU) Elderly on small dose of insulin can be switched to SU
Correct
Incorrect
-
Question 10 of 31
10. Question
The following are indications for sulponylurea (SU) Elderly with visual problem if insulin need is less
Correct
Incorrect
-
Question 11 of 31
11. Question
The following are indications for sulponylurea (SU) DM controlled with diet during intercurrent infections
Correct
Incorrect
-
Question 12 of 31
12. Question
Sulphonyl ureas are contraindicated in: Pregnancy
Correct
Incorrect
-
Question 13 of 31
13. Question
Sulphonyl ureas are contraindicated in: Type 1 diabetes
Correct
Incorrect
-
Question 14 of 31
14. Question
Sulphonyl ureas are contraindicated in: Diabetic ketoacidosis
Correct
Incorrect
-
Question 15 of 31
15. Question
Sulphonyl ureas are contraindicated in: Severe renal failure
Correct
Incorrect
-
Question 16 of 31
16. Question
The following are true regarding sulphonyl ureas Can be combined with other non SU agents and insulin
Correct
Incorrect
-
Question 17 of 31
17. Question
The following are true regarding sulphonyl ureas They are ineffective in 10-20% of people on first use
Correct
Incorrect
-
Question 18 of 31
18. Question
The following are true regarding sulphonyl ureas About 5-10% will fail to respond for each subsequent year of use
Correct
Incorrect
-
Question 19 of 31
19. Question
Reasons for failure to respond to sulphonyl ureas include: Decreasing beta-cell function
Correct
Incorrect
-
Question 20 of 31
20. Question
Reasons for failure to respond to sulphonyl ureas include: Nonadherence to treatment
Correct
Incorrect
-
Question 21 of 31
21. Question
Reasons for failure to respond to sulphonyl ureas include: Obesity
Correct
Incorrect
-
Question 22 of 31
22. Question
Reasons for failure to respond to sulphonyl ureas include: Insufficient exercise
Correct
Incorrect
-
Question 23 of 31
23. Question
Reasons for failure to respond to sulphonyl ureas include: Stress including intercurrent illness
Correct
Incorrect
-
Question 24 of 31
24. Question
The treatment of choice in a thin type 2 diabetes is: Sulphonyl urea, if fails then add metformin, if fails add insulin
Correct
Incorrect
-
Question 25 of 31
25. Question
The treatment of choice in a thin type 2 diabetes is: Sulphonyl urea, if fails then replace with metformin, if fails add insulin
Correct
Incorrect
-
Question 26 of 31
26. Question
The treatment of choice in a thin type 2 diabetes is: Sulphonyl urea, if fails then add metformin, if fails replace with insulin
Correct
Incorrect
-
Question 27 of 31
27. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add insulin
Correct
Incorrect
-
Question 28 of 31
28. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add sulphonyl urea
Correct
Incorrect
-
Question 29 of 31
29. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add Pioglitazone
Correct
Incorrect
-
Question 30 of 31
30. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Add an incretin
Correct
Incorrect
-
Question 31 of 31
31. Question
The choice in treatment of an obese type 2 diabetes if diet plus exercise and metformin do not achieve predetermined goals of therapy: Perform metabolic surgery
Correct
Incorrect
To take advantage of free full access to the education program. Sign-in / Fill the registration
Prof. Kaushik Ramaiya
Prof. Kaushik Ramaiya, MB,ChB, MMed. is Consultant Physician (Internal Medicine / Endocrinology) and Chief Executive Officer at Shree Hindu Mandal Hospital, Dar es Salaam, Tanzania, Hon. Professor of Medicine & Global Health at Liverpool School of Tropical Medicine, UK., and Hon. Lecturer at the Department of Internal Medicine at Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam.
Prof. Ramaiya has been actively involved in research on diabetes for many years. He specialised, among other topics, on glucose tolerance and cardiovascular disease risk factors and mainly focused on Indian communities living in Africa.